Notice：Luxna Biotech and Head Office for Open Innovation Business Development Strategy, Tohoku University Announce the Initiation of the Collaborative Research for Creation of Antisense Oligonucleotide for the Treatment of Hearing Loss 2023/12/22 Notice Read
Our President CEO, Mr. Hideaki Sato, will participate in “Global Finance & Innovation Forum in Osaka 2023” as a speaker. 2023/11/21 Event Read
We will be exhibiting at the SME Support, JAPAN Exhibition Booth at Bio Japan 2023. 2023/09/28 Event Read
We are selected as finalists for “Citeline Pharma Intelligence Awards Japan 2023”. 2023/09/26 Notice Read
